HomeCompareMDSY vs DIVO

MDSY vs DIVO: Dividend Comparison 2026

MDSY yields 273.97% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MDSY wins by $829.73M in total portfolio value
10 years
MDSY
MDSY
● Live price
273.97%
Share price
$0.73
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$829.76M
Annual income
$482,976,705.87
Full MDSY calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — MDSY vs DIVO

📍 MDSY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMDSYDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MDSY + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MDSY pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MDSY
Annual income on $10K today (after 15% tax)
$23,287.67/yr
After 10yr DRIP, annual income (after tax)
$410,530,199.99/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, MDSY beats the other by $410,529,365.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MDSY + DIVO for your $10,000?

MDSY: 50%DIVO: 50%
100% DIVO50/50100% MDSY
Portfolio after 10yr
$414.89M
Annual income
$241,488,843.77/yr
Blended yield
58.20%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MDSY buys
0
DIVO buys
0
No recent congressional trades found for MDSY or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMDSYDIVO
Forward yield273.97%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$829.76M$30.7K
Annual income after 10y$482,976,705.87$981.68
Total dividends collected$793.91M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MDSY vs DIVO ($10,000, DRIP)

YearMDSY PortfolioMDSY Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$38,097$27,397.26$11,349$649.42+$26.7KMDSY
2$138,312$97,547.72$12,833$688.83+$125.5KMDSY
3$478,971$330,977.72$14,459$727.90+$464.5KMDSY
4$1,583,686$1,071,187.07$16,238$766.49+$1.57MMDSY
5$5,004,645$3,310,100.73$18,179$804.47+$4.99MMDSY
6$15,130,978$9,776,007.79$20,293$841.71+$15.11MMDSY
7$43,813,187$27,623,040.05$22,591$878.14+$43.79MMDSY
8$121,632,577$74,752,467.62$25,087$913.65+$121.61MMDSY
9$324,095,536$193,948,677.87$27,791$948.18+$324.07MMDSY
10$829,758,929$482,976,705.87$30,718$981.68+$829.73MMDSY

MDSY vs DIVO: Complete Analysis 2026

MDSYStock

MDSY is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in MDSY shares.

Full MDSY Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this MDSY vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MDSY vs SCHDMDSY vs JEPIMDSY vs OMDSY vs KOMDSY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.